Sage Therapeutics, Inc. Accrued Liabilities, Current
Sage Therapeutics, Inc. had Accrued Liabilities, Current of $42.07 million as of 2025-06-30, per its 10-Q filed 2025-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2025-07-30
- 2025-06-30: Accrued Liabilities, Current $42.07M.
- 2025-03-31: Accrued Liabilities, Current $42.53M.
- 2024-12-31: Accrued Liabilities, Current $57.60M.
- 2024-09-30: Accrued Liabilities, Current $53.20M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2025-06-30 | $42.07M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $42.53M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $57.60M 10-Q · filed 2025-07-30 |
| 2024-09-30 | $53.20M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $58.98M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $52.01M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $67.26M 10-K · filed 2025-02-11 |
| 2023-09-30 | $114.90M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $79.80M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $64.75M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $72.67M 10-K · filed 2024-02-14 |
| 2022-09-30 | $85.01M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $76.27M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $63.05M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $67.28M 10-K · filed 2023-02-16 |
| 2021-09-30 | $66.80M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $61.62M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $51.42M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $54.85M 10-K · filed 2022-02-24 |
| 2020-09-30 | $46.76M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $53.33M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $52.18M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $86.62M 10-K · filed 2021-02-24 |
| 2019-09-30 | $78.13M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $58.91M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $47.65M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $51.99M 10-K · filed 2020-02-27 |
| 2018-09-30 | $48.65M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $39.58M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $29.52M 10-Q · filed 2018-05-03 |
| 2017-12-31 | $42.60M 10-K · filed 2019-02-19 |
| 2017-09-30 | $36.81M 10-Q · filed 2017-11-02 |
| 2017-06-30 | $26.24M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $23.65M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $22.35M 10-K · filed 2018-02-22 |
| 2016-09-30 | $17.09M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $12.38M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $11.43M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $10.15M 10-K · filed 2017-02-24 |
| 2015-09-30 | $6.40M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $5.16M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $5.52M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $4.69M 10-K · filed 2016-02-29 |
| 2014-09-30 | $2.85M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.07M 10-Q · filed 2014-08-14 |
| 2013-12-31 | $327.00K 10-K · filed 2015-03-06 |